ABBV logo

AbbVie (ABBV) Cost Of Goods Sold

Annual Cost Of Goods Sold

$16.90 B
-$3.51 B-17.20%

December 1, 2024


Summary


Performance

ABBV Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVexpensesmetrics:

Quarterly Cost Of Goods Sold

$4.40 B
+$184.00 M+4.37%

December 1, 2024


Summary


Performance

ABBV Quarterly Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVexpensesmetrics:

TTM Cost Of Goods Sold

$16.90 B
-$1.31 B-7.18%

December 1, 2024


Summary


Performance

ABBV TTM Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVexpensesmetrics:

Cost Of Goods Sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

ABBV Cost Of Goods Sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.2%+4.4%-7.2%
3 y3 years-3.1%+5.4%-0.2%
5 y5 years+127.2%+119.1%+127.2%

ABBV Cost Of Goods Sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.2%at low-32.2%+10.3%-17.6%at low
5 y5-year-17.2%+127.2%-32.2%+126.4%-17.6%+127.2%
alltimeall time-17.2%+316.7%-32.2%+379.9%-17.6%+1300.1%

AbbVie Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Dec 2024
$16.90 B(-17.2%)
$4.40 B(+4.4%)
$16.90 B(-7.2%)
Sep 2024
-
$4.21 B(+0.2%)
$18.21 B(-11.1%)
Jun 2024
-
$4.20 B(+2.6%)
$20.48 B(-0.2%)
Mar 2024
-
$4.09 B(-28.2%)
$20.52 B(+0.5%)
Dec 2023
$20.41 B(+17.2%)
$5.70 B(-12.0%)
$20.41 B(+8.1%)
Sep 2023
-
$6.49 B(+52.9%)
$18.88 B(+8.4%)
Jun 2023
-
$4.24 B(+6.4%)
$17.42 B(+0.4%)
Mar 2023
-
$3.99 B(-4.4%)
$17.35 B(-0.4%)
Dec 2022
$17.41 B(-0.2%)
$4.17 B(-17.0%)
$17.41 B(-0.9%)
Sep 2022
-
$5.02 B(+20.4%)
$17.56 B(+3.7%)
Jun 2022
-
$4.17 B(+2.9%)
$16.93 B(-2.0%)
Mar 2022
-
$4.05 B(-6.2%)
$17.29 B(-0.9%)
Dec 2021
$17.45 B(+13.4%)
$4.32 B(-1.6%)
$17.45 B(-2.0%)
Sep 2021
-
$4.39 B(-2.9%)
$17.81 B(-3.6%)
Jun 2021
-
$4.52 B(+7.4%)
$18.47 B(+4.6%)
Mar 2021
-
$4.21 B(-10.1%)
$17.66 B(+14.8%)
Dec 2020
$15.39 B(+106.8%)
$4.68 B(-7.2%)
$15.39 B(+21.1%)
Sep 2020
-
$5.05 B(+36.1%)
$12.71 B(+32.7%)
Jun 2020
-
$3.71 B(+91.1%)
$9.58 B(+24.6%)
Mar 2020
-
$1.94 B(-3.2%)
$7.69 B(+3.3%)
Dec 2019
$7.44 B(-3.6%)
$2.01 B(+4.5%)
$7.44 B(-0.2%)
Sep 2019
-
$1.92 B(+5.6%)
$7.46 B(+1.2%)
Jun 2019
-
$1.82 B(+7.4%)
$7.37 B(-1.5%)
Mar 2019
-
$1.69 B(-16.2%)
$7.49 B(-3.0%)
Dec 2018
$7.72 B(+9.6%)
$2.02 B(+10.2%)
$7.72 B(-3.2%)
Sep 2018
-
$1.83 B(-5.1%)
$7.98 B(+2.8%)
Jun 2018
-
$1.93 B(+0.4%)
$7.76 B(+5.5%)
Mar 2018
-
$1.93 B(-15.5%)
$7.35 B(+4.4%)
Dec 2017
$7.04 B
$2.28 B(+41.2%)
$7.04 B(+11.5%)
DateAnnualQuarterlyTTM
Sep 2017
-
$1.62 B(+5.7%)
$6.32 B(+1.8%)
Jun 2017
-
$1.53 B(-5.4%)
$6.20 B(+2.0%)
Mar 2017
-
$1.62 B(+4.0%)
$6.08 B(+4.2%)
Dec 2016
$5.83 B(+29.6%)
$1.55 B(+3.3%)
$5.83 B(+1.4%)
Sep 2016
-
$1.50 B(+7.0%)
$5.75 B(+6.2%)
Jun 2016
-
$1.41 B(+2.6%)
$5.42 B(+9.9%)
Mar 2016
-
$1.37 B(-7.2%)
$4.93 B(+9.5%)
Dec 2015
$4.50 B(+1.7%)
$1.48 B(+26.4%)
$4.50 B(+8.6%)
Sep 2015
-
$1.17 B(+27.4%)
$4.14 B(+1.8%)
Jun 2015
-
$916.00 M(-2.8%)
$4.07 B(-4.6%)
Mar 2015
-
$942.00 M(-15.8%)
$4.27 B(-3.6%)
Dec 2014
$4.43 B(-3.4%)
$1.12 B(+2.3%)
$4.43 B(-3.6%)
Sep 2014
-
$1.09 B(-1.7%)
$4.59 B(+0.0%)
Jun 2014
-
$1.11 B(+1.2%)
$4.59 B(+1.3%)
Mar 2014
-
$1.10 B(-14.2%)
$4.53 B(-1.2%)
Dec 2013
$4.58 B(+1.6%)
$1.28 B(+17.4%)
$4.58 B(+0.4%)
Sep 2013
-
$1.09 B(+3.6%)
$4.56 B(+1.7%)
Jun 2013
-
$1.05 B(-8.6%)
$4.49 B(-0.4%)
Mar 2013
-
$1.15 B(-8.9%)
$4.50 B(-0.1%)
Dec 2012
$4.51 B(-2.8%)
$1.26 B(+24.8%)
$4.51 B(+2.0%)
Sep 2012
-
$1.01 B(-5.5%)
$4.42 B(-3.0%)
Jun 2012
-
$1.07 B(-7.2%)
$4.55 B(-0.7%)
Mar 2012
-
$1.16 B(-1.7%)
$4.59 B(-1.1%)
Dec 2011
$4.64 B(+8.1%)
$1.18 B(+2.3%)
$4.64 B(+33.9%)
Sep 2011
-
$1.15 B(+3.7%)
$3.46 B(+49.6%)
Jun 2011
-
$1.11 B(-8.3%)
$2.31 B(+91.7%)
Mar 2011
-
$1.21 B
$1.21 B
Dec 2010
$4.29 B(+5.8%)
-
-
Dec 2009
$4.06 B
-
-

FAQ

  • What is AbbVie annual cost of goods sold?
  • What is the all time high annual cost of goods sold for AbbVie?
  • What is AbbVie annual cost of goods sold year-on-year change?
  • What is AbbVie quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for AbbVie?
  • What is AbbVie quarterly cost of goods sold year-on-year change?
  • What is AbbVie TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for AbbVie?
  • What is AbbVie TTM cost of goods sold year-on-year change?

What is AbbVie annual cost of goods sold?

The current annual cost of goods sold of ABBV is $16.90 B

What is the all time high annual cost of goods sold for AbbVie?

AbbVie all-time high annual cost of goods sold is $20.41 B

What is AbbVie annual cost of goods sold year-on-year change?

Over the past year, ABBV annual cost of goods sold has changed by -$3.51 B (-17.20%)

What is AbbVie quarterly cost of goods sold?

The current quarterly cost of goods sold of ABBV is $4.40 B

What is the all time high quarterly cost of goods sold for AbbVie?

AbbVie all-time high quarterly cost of goods sold is $6.49 B

What is AbbVie quarterly cost of goods sold year-on-year change?

Over the past year, ABBV quarterly cost of goods sold has changed by +$184.00 M (+4.37%)

What is AbbVie TTM cost of goods sold?

The current TTM cost of goods sold of ABBV is $16.90 B

What is the all time high TTM cost of goods sold for AbbVie?

AbbVie all-time high TTM cost of goods sold is $20.52 B

What is AbbVie TTM cost of goods sold year-on-year change?

Over the past year, ABBV TTM cost of goods sold has changed by -$1.31 B (-7.18%)